A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine–Experienced Adults 50 Years of Age or Older …
P Scott, M Haranaka, JH Choi, H Stacey… - Clinical Infectious …, 2024 - academic.oup.com
Background Pneumococcal diseases cause considerable morbidity and mortality in adults.
V116 is an investigational 21-valent pneumococcal conjugate vaccine (PCV) specifically …
V116 is an investigational 21-valent pneumococcal conjugate vaccine (PCV) specifically …
Advances in the pathogenesis and treatment of pneumococcal meningitis
Y Xu, J Wang, X Qin, J Liu - Virulence, 2024 - Taylor & Francis
Streptococcus pneumoniae is a common pathogen associated with community-acquired
bacterial meningitis, characterized by high morbidity and mortality rates. While vaccination …
bacterial meningitis, characterized by high morbidity and mortality rates. While vaccination …
Antibacterial Activity of Thesium chinense Turcz Extract Against Bacteria Associated with Upper Respiratory Tract Infections
J Wei, C Zhang, W Ma, J Ma, Z Liu… - Infection and Drug …, 2023 - Taylor & Francis
Purpose The drug resistance of Staphylococcus aureus, Streptococcus pneumoniae,
Streptococcus pyogenes and Haemophilus influenzae has become more and more serious …
Streptococcus pyogenes and Haemophilus influenzae has become more and more serious …
Monitoring Over a Decade in the Serotype Prevalence of Streptococcus pneumoniae in Iran: A Systematic Review and Meta-analysis
S Mamishi, B Pourakbari, A Bahador… - … Current Drug Targets …, 2024 - ingentaconnect.com
Background: There is no comprehensive information about the circulating serotypes of
Streptococcus pneumoniae in Iran in recent years. This study aimed to summarize …
Streptococcus pneumoniae in Iran in recent years. This study aimed to summarize …
Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007–21
JJ Schellenberg, HJ Adam, MR Baxter… - Journal of …, 2024 - academic.oup.com
Background Lower respiratory infections and invasive disease caused by Streptococcus
pneumoniae serotype 3 remain major clinical challenges around the world, despite …
pneumoniae serotype 3 remain major clinical challenges around the world, despite …
Prime-boost-type PspA3+ 2 mucosal vaccine protects cynomolgus macaques from intratracheal challenge with pneumococci
C Yokota, K Fujimoto, N Yamakawa, M Kono… - Inflammation and …, 2023 - Springer
Background Although vaccination is recommended for protection against invasive
pneumococcal disease, the frequency of pneumococcal pneumonia is still high worldwide …
pneumococcal disease, the frequency of pneumococcal pneumonia is still high worldwide …
[HTML][HTML] Development of a Recombinant Live Attenuated Influenza Vaccine Virus Expressing Pneumococcal Surface Antigen A as a Strategy for Combined Protection …
AS Matushkina, IN Isakova-Sivak… - The Open …, 2024 - openmicrobiologyjournal.com
Methods A recombinant live attenuated influenza virus (LAIV) expressing PspA fragment in a
modified hemagglutinin was rescued on the A/Leningrad/134/17/57 (H2N2) backbone. This …
modified hemagglutinin was rescued on the A/Leningrad/134/17/57 (H2N2) backbone. This …
Eficácia da vacinação pneumocócica na redução de infecções respiratórias em crianças: uma revisão sistemática: UMA REVISÃO SISTEMÁTICA
RN da Silveira Gomes… - Journal of Medical …, 2024 - journalmbr.com.br
Esta revisão sistemática teve como objetivo avaliar a eficácia da vacinação pneumocócica
em aumentar os níveis de IgG e reduzir a incidência de sinusite e adenoidite de repetição …
em aumentar os níveis de IgG e reduzir a incidência de sinusite e adenoidite de repetição …
[PDF][PDF] Public Health Impact of implementing a 20-valent pneumococcal conjugate vaccine in Turkish pediatric population
L Huang, W Wannaadisai, T Nassar… - …, 2024 - pfizermedical.pfizerpro.com
• Clinical impact was assessed by comparing the number of pneumococcal disease cases
and deaths after implementing a pediatric NIP with PCV20 vs. PCV13. Specifically, it …
and deaths after implementing a pediatric NIP with PCV20 vs. PCV13. Specifically, it …